Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBNK
3476
DELISTED
Territorial Bancorp Inc.
TBNK
| $323K | ﹤0.01% |
13,435
-35
| -0.3% | -$735 |
|
3477
Harmony Gold Mining
HMY
$9.84B
| $322K | ﹤0.01% |
+94,577
| New | +$298K |
|
3478
8x8 Inc
EGHT
$269M
| $320K | ﹤0.01% |
74,134
+23,881
| +48% | +$96K |
|
3479
BGC Group
BGC
$5.45B
| $319K | ﹤0.01% |
84,668
+60,090
| +244% | +$237K |
|
3480
Orrstown Financial Services
ORRF
$840M
| $319K | ﹤0.01% |
13,773
+2,317
| +20% | +$59.2K |
|
3481
Sphere Entertainment
SPHR
$5.14B
| $318K | ﹤0.01% |
7,075
+2,510
| +55% | +$114K |
|
|
NAPA
3482
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $318K | ﹤0.01% |
19,176
+17,608
| +1,123% | +$271K |
|
3483
Peoples Bancorp
PEBO
$1.5B
| $317K | ﹤0.01% |
11,236
+8,535
| +316% | +$251K |
|
|
LGF.A
3484
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $316K | ﹤0.01% |
55,414
+22,274
| +67% | +$157K |
|
3485
MultiSensor AI Holdings Warrant
MSAIW
$705K
| $316K | ﹤0.01% |
30,994
-900
| -3% | -$59 |
|
|
TVRD
3486
Tvardi Therapeutics
TVRD
$19.7M
| $316K | ﹤0.01% |
818
+326
| +66% | +$124K |
|
3487
Goosehead Insurance
GSHD
$2.2B
| $315K | ﹤0.01% |
9,165
+3,396
| +59% | +$127K |
|
3488
Regional Management Corp
RM
$301M
| $314K | ﹤0.01% |
11,190
+2,485
| +29% | +$73.2K |
|
3489
Tredegar Corp
TG
$265M
| $313K | ﹤0.01% |
30,672
+24,068
| +364% | +$251K |
|
|
LGF.B
3490
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $313K | ﹤0.01% |
57,653
+47,266
| +455% | +$314K |
|
3491
Cytek Biosciences
CTKB
$545M
| $313K | ﹤0.01% |
30,659
+25,818
| +533% | +$347K |
|
|
HAPN
3492
Happen Inc
HAPN
$2.21B
| $313K | ﹤0.01% |
35,524
+28,729
| +423% | +$296K |
|
3493
TriMas Corp
TRS
$1.43B
| $312K | ﹤0.01% |
11,247
+9,040
| +410% | +$242K |
|
3494
GH Research
GHRS
$1.93B
| $312K | ﹤0.01% |
32,090
| – | – |
|
|
MFA
3495
MFA Financial
MFA
$926M
| $312K | ﹤0.01% |
31,661
+26,852
| +558% | +$270K |
|
3496
Radware
RDWR
$1.1B
| $312K | ﹤0.01% |
15,778
-9,357
| -37% | -$196K |
|
|
FSP
3497
Franklin Street Properties
FSP
$47.2M
| $311K | ﹤0.01% |
114,074
+10,884
| +11% | +$30.1K |
|
3498
CALL
Opendoor
OPEN
$3.64B
| $311K | ﹤0.01% |
+276,623
| New | +$530K |
|
3499
iShares Global Consumer Staples ETF
KXI
$1.06B
| $310K | ﹤0.01% |
5,200
| – | – |
|
3500
Pitney Bowes
PBI
$2.4B
| $310K | ﹤0.01% |
81,477
+10,861
| +15% | +$36.6K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.